Documentos de Académico
Documentos de Profesional
Documentos de Cultura
shock séptico
Epidemiologia
Definiciones
Fisiopatología
Pronostico y Reflexiones
• Etimología :
PUTREFACCION O DESCOMPOSICION
Epidemiologia
https://www.worldsepsisday.org/sepsis
SEPSIS 1
SIRS
Intensive Care Med. 2003 Apr;29(4):530-8. doi: 10.1007/s00134-003-1662-x. Epub 2003 Mar 28.
Intensive Care Med. 2003 Apr;29(4):530-8. doi: 10.1007/s00134-003-1662-x. Epub 2003 Mar 28.
SEPSIS 3
REVIEW ARTICLECRITICAL CARE MEDICINE Severe Sepsis and Septic Shock List of authors.Derek C. Angus, M.D., M.P.H., and Tom van der Poll, M.D.,
Ph.D.
REVIEW ARTICLECRITICAL CARE MEDICINE Severe Sepsis and Septic Shock List of authors.Derek C. Angus, M.D., M.P.H., and Tom van der Poll, M.D.,
Ph.D.
REVIEW ARTICLECRITICAL CARE MEDICINE Severe Sepsis and Septic Shock List of authors.Derek C. Angus, M.D., M.P.H., and Tom van der Poll, M.D.,
Ph.D.
REVIEW ARTICLECRITICAL CARE MEDICINE Severe Sepsis and Septic Shock List of authors.Derek C. Angus, M.D., M.P.H., and Tom van der Poll, M.D.,
Ph.D.
ETIOLOGIA
https://www.worldsepsisday.org/sepsis
PRESENTACION
CLINICA
https://www.worldsepsisday.org/sepsis
Identificar la disfunción o fracaso de órganos en un paciente
Séptico.
• Sistema de medición de seis disfunciones orgánicas
• 0 (normal) 4 (mas anormal)
• Puntuación : 0 -24
• A mayor puntuación SOFA, mayor será probabilidad de mortalidad.
JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
Se asigna 1 punto por cada criterio
1.Hipotensión sostenida
2.Uso de drogas vasopresoras para mantener la PAM>= 65 mmHg
3.Lactato > 2 mmol/L
JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
Sepsis-3 y las nuevas definiciones, ¿es tiempo de
abandonar SIRS? Elsa R Neira-Sanchez1,2,3, Germán
Málaga1,3,a 1 Departamento de Medicina, Hospital
Nacional Cayetano Heredia. Lima, Perú.
55 EXPERTOS DE 25 ORGANIZACIONES INTERNACIONALES
CINCO AREAS : HEMODIAMIA, INFECCION, TERAPIA
ADYUVANTE, METABOLISMO Y VENTILACION.
1. RESUCITACION INICIAL
2. DETECCIÓN DE SEPSIS Y 12. ANTICOAGULANTES
MEJORA DEL RENDIMIENTO 13. VENTILACION MECANICA
3. DIAGNOSTICO 14. SEDACION Y ANALGESIA
4. TERAPIA ANTIMICROBIANA 15. CONTROL DE GLUCOSA
5. FUENTE DE CONTROL 16. TERAPIA DE REEMPLAZO RENAL
6. TERAPIA DE FLUIDOS 17. TERAPIA DE BICARBONATO
7. MEDICACION CON VASOACTIVOS 18. PROFILAXIS DE
8. CORTICOIDES TROMBOEMBOLISMO VENOSO
9. HEMODERIVADOS 19. PROFILAXIS DE ULCERAS POR ESTRÉS
20. TERAPIA DE NUTRICION
10. INMUNOGLOBULINAS 21. METAS DE ATENCION
11. PURIFICACION SANGUINEA
Rhodes Andrew, Evans, Laura y colaboradores. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock:2016
Critical Care Medicine. Jan 2017
Critical Care Medicine: June 2018 - Volume 46 - Issue 6 - p 997–1000 doi: 10.1097/CCM.0000000000003119 The
Surviving Sepsis Campaign Bundle: 2018 Update
TAMIZAJE
TENER PROTOCOLOS DE SEPSIS
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
DIAGNOSTICO ADMISION UCI
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
MANEJO: CONTROL DE INFECCION
PROCALCITONINA
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
ELECCION DEL ANTIBIOTICO
RIESGO DE MRSA:
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
INICIAR ANTIFUNGICOS EN PACIENTES CON
NEUTROPENIA FEBRIL EN QUIENES TRAS 4 – 7 DIAS
DE COBERTURA ANTIBACTERIANA CONTINUA FEBRIL
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
CONTROL DE LA FUENTE : ANTES DE LAS 6 O 12 HORAS
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
PROCALCITONINA PARA
DESCONTINUAR ATB
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
RESUCITACION INICIAL
USO DE CRISTALOIDES 30 ML/KG EN LAS
PRIMERAS 3 HORAS
MONITOREO:
• MEDIDAS DINAMICAS
• MEDIDA DE LACTATO
• MEDIDA DE LLENADO CAPILAR
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
FLUIDOTERAPIA ENDOVENOSA
• SINTETICOS:
GELATINAS
ALMIDONES
DEXTRANOS
• NATURALES:
ALBUMINA
Resuscitation Targeting Peripheral Perfusion Status vs Serum Lactate and Mortality in Patients With Septic Shock
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
OTRAS MEDIDAS : VENTILACION
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
OTRAS MEDIDAS : VENTILACION
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
OTRAS MEDIDAS
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
OTRAS MEDIDAS
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
QUE NO SE RECOMIENDA
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med (2021) 47:1181–1247
https://doi.org/10.1007/s00134-021-06506-y
PRONOSTICO
https://www.worldsepsisday.org/sepsis
Reflexiones finales
TAMIZAJE : NO USE UNA UNICA ESCALA ADMINISTRACION DE ATB: GUIADA POR PK/PD •VOLUMENT IDDAL BAJO
TIEMPOS: BETALACTAMICOS EN BOLO SEGUIDO DE •PEEP ALTO